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Abstract
Introduction: Preterm delivery (<37 weeks) predicts later cardiovascular disease risk 
in mothers, even among normotensive deliveries. However, development of subclini-
cal cardiovascular risk before and after preterm delivery is not well understood. We 
sought to investigate differences in life course cardiovascular risk factor trajectories 
based on preterm delivery history.
Material and methods: The HUNT Study (1984-2008) linked with the Medical Birth 
Registry of Norway (1967-2012) yielded clinical measurements and pregnancy out-
comes for 19 806 parous women with normotensive first deliveries. Women had up 
to three measurements of body mass index, waist-to-hip ratio, blood pressure, lipids, 
non-fasting glucose, and C-reactive protein during follow up between 21 years before 
2  |     MARKOVITZ eT Al.
1  | INTRODUC TION
Preterm delivery, <37 weeks gestation, is associated with a two- to 
three-fold greater risk of maternal cardiovascular disease (CVD).1 
Although this association is likely due to shared etiologic pathways,2 
which specific biologic pathways might be involved is not well un-
derstood. There is some evidence that preterm delivery is associated 
with subclinical markers of CVD both before3-5 and after5-8 deliv-
ery. However, these associations diminish after taking into account 
hypertensive disorders of pregnancy,3-7 a common reason for pre-
term delivery.9 Whether preterm delivery in the absence of hyper-
tension is associated with subclinical markers of CVD risk remains 
inconclusive.
Characterizing how subclinical CVD risk factors develop 
across the life course is critical to understanding how CVD risk 
emerges in women with a history of preterm delivery. To our 
knowledge, only one study has examined preterm delivery and 
CVD risk factors measured both pre-pregnancy and postpar-
tum.5 Other studies examined only differences in CVD risk fac-
tors at a single point in time either pre- or postpartum and were 
not able to evaluate how risk factor trajectories evolved with 
time since pregnancy.
We examined differences in CVD risk factor trajectories based 
on preterm delivery history using the population-based Nord-
Trøndelag Health Study (the HUNT Study) linked with the Medical 
Birth Registry of Norway (MBRN). Our study cohort allowed con-
sideration of measured anthropometric factors and biomarkers from 
21 years before to 41 years after first delivery to illustrate differ-
ences in risk factor levels across the life course.
2  | MATERIAL AND METHODS
2.1 | Study population
The HUNT Study is a population-based, open cohort study in 
Norway's Nord-Trøndelag county.10 Every decade, all current resi-
dents aged 20 years or older are identified from Statistics Norway's 
population registry and invited to participate in a health assessment 
survey. We examined data from the first three surveys: HUNT1 
(1984-86), HUNT2 (1995-97), and HUNT3 (2006-08), during which 
participants provided blood samples, clinical measurements, and 
completed questionnaires. Using Norway's unique personal identi-
fier, we linked HUNT data to the MBRN, which records all deliveries 
in Norway. We identified a total of 25 922 female HUNT participants 
whose first delivery was recorded between the start of the birth reg-
istry in 1967 and the end of our data collection in 2012. Our study 
population included 19 806 women after excluding women with 
first deliveries complicated by hypertensive disorders of pregnancy, 
multiple gestation pregnancies, and incomplete records (Figure 1). 
Hypertensive disorders of pregnancy included a pre-pregnancy di-
agnosis of hypertension or diagnoses of preeclampsia or gestational 
hypertension, as identified from the MBRN.
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to 41 years after first delivery. Using mixed effects models, we compared risk factor 
trajectories for women with preterm vs term/postterm first deliveries.
Results: Trajectories overlapped for women with preterm compared with term/post-
term first deliveries for all cardiovascular risk factors examined. For instance, the 
mean difference in systolic blood pressure in women with preterm first deliveries 
compared with those with term deliveries was 0.2 mm Hg (95% CI −1.8 to 2.3) at age 
20 and 1.5 mm Hg (95% CI −0.5 to 3.6) at age 60.
Conclusions: A history of preterm delivery was not associated with different life 
course trajectories of common cardiovascular risk factors in our study population. 
This suggests that the robust association between preterm delivery and cardiovas-
cular end points in Norway or similar contexts is not explained by one or more com-
monly measured cardiovascular risk factors. Overall, we did not find evidence for a 
single cardiovascular disease prevention strategy that would reduce risk among the 
majority of women who had preterm delivery.
K E Y W O R D S
anthropometry, blood pressure, C-reactive protein, gestational age, lipids, maternal health, 
premature birth, women's health
Key Message
Women with a normotensive preterm first delivery did not 
have consistently elevated levels of commonly measured 
cardiovascular risk factors across their life course.
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2.2 | Preterm delivery
Using the MBRN, we identified gestation length based on ultrasound 
dating where available (13% of deliveries) or last menstrual period. 
Our primary analysis considered preterm delivery as a dichotomous 
exposure (<37 vs ≥37 weeks gestation), but in sensitivity analyses, 
we also considered gestation length in categories of very preterm 
(20-31 weeks), moderately preterm (32-36 weeks), early term (37-
38 weeks), term (39-40), and late term/postterm (41-44 weeks). 
Gestation length recorded in the MBRN has very good validity.11
F I G U R E  1   1Flow chart of the study population
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2.3 | Cardiovascular risk factors
We identified cardiovascular risk factors through clinical meas-
urements and serum samples collected at HUNT examinations by 
trained staff. At the time of examinations, participants ranged in age 
from 20 through 77 and examinations occurred between 21 years 
before to 41 years after participants’ first delivery (see Supporting 
Information Figure S1). Some risk factors were collected only during 
later HUNT surveys, with a summary of data collection and sample 
sizes provided in the Supporting Information (Table S1).
All HUNT examinations included clinical measurements of 
weight and height, from which we calculated body mass index (BMI; 
kg/m2). HUNT2 and HUNT3 included waist and hip circumference 
measurements from which we calculated waist-to-hip ratio. All 
HUNT examinations measured blood pressure and for women who 
reported taking antihypertensives (n = 1668), we used the recom-
mended approach12,13 of adding 10 mm Hg to systolic and 5 mm Hg 
to diastolic blood pressure levels. Staff collected non-fasting serum 
samples in HUNT2 and HUNT3 from which we measured lipids, 
glucose, and high-sensitivity C-reactive protein (hs-CRP). Using 
total cholesterol and high-density lipoprotein cholesterol (HDL-C), 
we calculated the total cholesterol/HDL-C ratio and non-HDL-C. 
In HUNT1, staff measured capillary glucose for participants over 
age 40 years, which we multiplied by 1.11 to approximate serum 
glucose values.14 In HUNT2 and HUNT3, technicians directly mea-
sured serum glucose for all participants. In HUNT2, collection of 
hs-CRP was limited to participants from a sample of four out of the 
24 included municipalities (n = 2070) and expanded to all partici-
pants in HUNT3. Supporting Information (Table S2) includes addi-
tional details.
2.4 | Covariates
From HUNT questionnaires, we identified use of antihypertensive 
medication, hours since last meal (<1, 1, 2, 3, 4, 5, or ≥6 hours), fam-
ily history of CVD (ie, any reported myocardial infarction or angina 
pectoris in siblings or parents), smoking initiation by age 20 years, 
highest obtained educational level, and work titles. Education level 
was omitted from HUNT3 and we instead derived it from work ti-
tles for 15% of women based on recommendation from Statistics 
Norway.15
2.5 | Statistical analyses
We compared cardiovascular risk factor trajectories as a function of 
age for women with and without a preterm first delivery using linear 
mixed effects models. Mixed effects models included a random in-
tercept and slope for each woman to account for repeated measure-
ments at up to three HUNT examinations and enabled estimation 
of within-woman trajectories.16 We modeled age using restricted 
cubic splines with four knots located at ages 23, 34, 44, and 60 years 
based on prespecified quantiles of the age distribution, as recom-
mended by Harrell.17 We log-transformed hs-CRP in all analyses.
Technical details about the models used are available in the 
Supporting Information (Appendix S1). We accounted for the tim-
ing of first delivery in the risk factor trajectories by including both 
a variable indicating whether the measurement occurred before or 
after first delivery (covariate Iij in Supporting Information Appendix 
S1 Equation 1) and a variable for continuous time since first deliv-
ery (covariate Tij in Supporting Information Appendix S1 Equation 1), 
which together modeled both short- and long-term changes in risk 
factors associated with pregnancy. Using interaction terms, we al-
lowed women with a preterm first delivery to have different age-re-
lated changes in risk factors (covariates PiAij and PiSijk in Supporting 
Information Appendix S1 Equation 2) as well as different pregnan-
cy-related changes (covariates PiIij and PiTij in Supporting Information 
Appendix S1 Equation 2), providing flexibility for trajectories to dif-
fer based on preterm delivery history. All models controlled for high-
est obtained education level, family history of CVD, smoking at age 
20 years, HUNT survey, age at first delivery, and time since last meal.
We present figures of estimated risk factor trajectories for 
women with and without a preterm first delivery. In secondary anal-
yses, we modeled gestation length in categories, keeping the same 
general model format. We present a comparison of mean risk factor 
levels by category of gestation length at 40, the study median age. 
A comparison of trajectories by categorized gestation length across 
the full age range is available in the Supporting Information. All anal-
yses were performed using Stata IC 13 and MLwiN18 version 2.34.
2.6 | Sensitivity analyses
We conducted sensitivity analyses among women with two or more 
measurements of each risk factor, for all risk factors but hs-CRP, to 
examine the impact of including single measures in trajectory mod-
els. We also examined clinical definitions rather than continuous risk 
factor levels where appropriate, for example, defining hypertension 
as systolic blood pressure ≥140, diastolic blood pressure ≥90, or a 
self-reported use of antihypertensives. Our main analyses focused 
on gestation lengths of first deliveries only, which enabled us to 
explicitly model the timing of the delivery without the complexity 
required to incorporate full delivery history. In sensitivity analyses, 
we instead modeled a history of any preterm delivery vs no preterm 
delivery controlling for parity and without explicitly modeling the 
timing of deliveries. We also conducted sensitivity analyses exclud-
ing deliveries that were unusually large for their gestation length, 
defined as a z-score >4 (n = 57) that may have been misclassified as 
preterm deliveries. Additionally, we performed sensitivity analyses 
excluding women with large- or small-for-gestational age deliveries 
and women with pre-existing or gestational diabetes, as well as an 
analysis where we excluded women with induced labor. Small and 
large for gestational age were defined as a birthweight in the lowest 
or highest 10th centile given gestational age and sex, based on a 
Norwegian reference population.19
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2.7 | Ethical approval
This project was approved by the Central Norway Regional 
Committee for Medical and Health Research Ethics (reference 
number: 2013/647, date of approval: 28 May 2015) and was ex-
empt from IRB review by Harvard T. H. Chan School of Public 
Health (reference number: IRB 16-1054, date of exemption: 28 
June 2016).
TA B L E  1   Description of covariates by preterm status of first delivery among parous HUNT participants with a normotensive first 







(n = 18 709)
Baseline characteristics
Maternal birth year, median (IQR) 1958 (1951-1967) 1958 (1951-1967)
Smoking history at age 20, n (%)
Never smoked daily 472 (43%) 8996 (48%)
Ever smoked daily 625 (57%) 9713 (52%)
Education, n (%)
Lower Secondary (≤9 years) 213 (19%) 3159 (17%)
Upper Secondary (10-12 years) 535 (49%) 8792 (47%)
Tertiary (>12 years) 349 (32%) 6758 (36%)
Family history of CVDa , n (%) 312 (28%) 5642 (30%)
Characteristics of first delivery
Age at first delivery, median (IQR) 22 (20-27) 23 (20-26)
Maternal pre-existing or gestational diabetes 15 (1%) 66 (0%)
Male gender 605 (55%) 9536 (51%)
Birthweight, n (%)
Small for gestational ageb  169 (15%) 2472 (13%)
Normal 735 (67%) 15 173 (81%)
Large for gestational agec  187 (17%) 1051 (6%)
Not available 6 (1%) 13 (0%)
Stillbirth, n (%) 112 (10%) 77 (0%)
Very preterm (< 32 weeks) 254 (23%) NA
Induced labor
1967-2012 164 (15%) 2890 (15%)
1985-2012d  103 (21%) 1326 (16%)
HUNT exam characteristics
Age at first HUNT exam, median (IQR) 32 (27-37) 32 (27-37)
No. of HUNT exams, n (%)
1 387 (35%) 6482 (35%)
2 345 (31%) 5840 (31%)
3 365 (33%) 6387 (34%)
HUNT exams relative to first delivery, n (%)
Before first delivery only 95 (9%) 1586 (8%)
After first delivery only 899 (82%) 15 521 (83%)
Before and after first delivery 103 (9%) 1593 (9%)
Abbreviations: CVD, cardiovascular disease; exam, examination; IQR, interquartile range.
aFamily history of CVD includes myocardial infarction or angina pectoris in siblings or parents. 
bDefined as a birthweight in the lowest 10th centile given gestational age and sex, based on a Norwegian reference population. 
cDefined as a birthweight in the highest 10th centile given gestational age and sex, based on a Norwegian reference population. 
dLabor initiation was better tracked for deliveries starting in 1985. 
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3  | RESULTS
After restricting to normotensive first deliveries, 5.5% were pre-
term. Women with a preterm first delivery were more likely smok-
ers and had lower education. Preterm first deliveries were more 
likely to be either small or large for their gestation length and much 
more likely to be stillbirths (Table 1). These differences were more 
pronounced with lower gestation length (Supporting Information 
Table S3). Among deliveries from 1985 to 2012 when labor initiation 
was better tracked,11 79% of preterm and 84% of term deliveries 
were spontaneous rather than provider-initiated.
Compared with women with a term first delivery, women with 
a preterm first delivery had a somewhat lower mean BMI from ap-
proximately age 30 years onward, with an estimated −0.5 kg/m2dif-
ference (95% CI −1.0 to −0.1) at age 60 years (Supporting Information 
Table S4), but had similar waist-to-hip ratios (Figure 2A,B). Systolic 
blood pressure was slightly higher for women with a preterm first 
delivery with a difference of 0.2 mm Hg (95% CI −1.8 to 2.3) at 
age 20 years and 1.5 mm Hg (95% CI: −0.5 to 3.6) at age 60 years, 
with similar small differences observed for diastolic blood pressure 
(Figure 2C,D). Lipid trajectories overlapped (Figure 3A-D), although 
there was some indication of higher triglycerides before a preterm 
delivery with an estimated difference of 10.6 mg/dL (95% CI −1.4 to 
22.6). Non-fasting glucose before delivery was higher by 5.3 mg/dL 
in women with a preterm first delivery (95% CI 1.9 to 8.8) and was 
somewhat higher following preterm delivery (Figure 3E). Women with 
a preterm first delivery also had slightly higher hs-CRP levels at earlier 
ages, with a 14% higher hs-CRP at age 20 years (95% CI −34% to 98%).
Gestation length and BMI at age 40 years had a U-shaped re-
lationship, with the lowest mean BMI values observed for women 
with early term (37-38 weeks) first deliveries and the highest for 
women with late term/postterm (41-44 weeks) first deliveries 
(Figure 4A). Women whose first deliveries were after 40 weeks of 
gestation also had the highest waist-to-hip ratios at age 40 years 
(Figure 4B). Figure 4C,D suggests a trend toward lower blood 
pressure values among women with longer gestation lengths, 
with the lowest mean blood pressure observed for women whose 
first deliveries were after 41 weeks of gestation. For blood-based 
measures (Figure 5), no clear trends by gestation length emerged. 
However, there was some indication that women who had moder-
ate preterm (32-36 weeks) or early term deliveries had less favor-
able lipid and glucose profiles by age 40 compared with women 
who had term deliveries (39-40 weeks). The associations seen 
between gestation length and risk factors at age 40 years were 
similar across the age range examined (Supporting Information 
Figures S2 and S3).
F I G U R E  2   Life course trajectories for clinically measured cardiovascular disease (CVD) risk factors among women with preterm and 
term/postterm normotensive first deliveries. Estimates are adjusted for age, HUNT survey, age at first delivery, highest obtained education 
level, family history of CVD, smoking at age 20 years, and time since last meal. For the purposes of illustration, we present trajectories in 
which age at first delivery was set to 23 years, the median age in our study population, and all other covariates were set to their means. As 
we had insufficient data to model the different risk factor levels typically seen during pregnancy and early postpartum, first pregnancy and 
3 months postpartum is depicted as a gap on trajectory graphs. Graphs are shown up to age 60 years, after which data are sparse
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The comparison of trajectories based on preterm delivery 
status was nearly identical when the analysis was restricted to 
women who contributed two or more measurements (Supporting 
Information Figures S4 and S5), when using clinical definitions 
(Supporting Information Figure S6), when examining a history of 
any preterm delivery (Supporting Information Figures S7 and S8), 
and when excluding deliveries unusually large for their gestation 
length (not shown). Excluding women with small or large for gesta-
tional age deliveries and pre-existing or gestational diabetes only 
led to minor changes, as did excluding provider-initiated deliveries 
(results not shown).
4  | DISCUSSION
We found no evidence of differences in cardiovascular risk factor 
trajectories based on preterm status in this longitudinal, population-
based study of normotensive first deliveries. Pre-pregnancy glucose 
tended to be higher among women who subsequently had a preterm 
delivery, but this difference did not appear to persist in the years 
following pregnancy.
Our findings suggest that most women with a normotensive 
preterm delivery will have few other strong indicators of an increased 
risk of CVD, based on commonly measured factors, in the decades 
F I G U R E  3   Life course trajectories for serum levels of cardiovascular disease (CVD) risk factors among women with preterm and term/
postterm normotensive first deliveries. Estimates are adjusted for age, HUNT survey, age at first delivery, highest obtained education level, 
family history of CVD, smoking at age 20 years, and time since last meal. For the purposes of illustration, we present trajectories in which 
age at first delivery was set to 23 years, the median age in our study population, and all other covariates were set to their means. As we 
had insufficient data to model the different risk factor levels typically seen during pregnancy and early postpartum, first pregnancy and 
3 months postpartum is depicted as a gap on trajectory graphs. Graphs are shown up to age 60 years, after which data are sparse
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following their first delivery. These null findings are consistent with 
the Avon Longitudinal Study of Parents and Children, which found 
similar 10-year Framingham risk scores for women with and with-
out a preterm delivery.7 However, previous studies of individual risk 
factors found conflicting results. After excluding or adjusting for 
hypertensive disorders of pregnancy, some previous studies found 
that anthropometric and blood pressure levels did not differ after a 
preterm delivery,6,7 whereas others observed higher BMI and blood 
pressure5,20 or higher rates of hypertension21 after a preterm deliv-
ery. The CARDIA study found that diastolic blood pressure increased 
across the childbearing period in women with a history of preterm 
delivery but decreased in women with term deliveries.20 Our data, in 
contrast, did not suggest differences in blood pressure changes from 
before the first pregnancy to after the first pregnancy by preterm 
delivery status.
Some studies were consistent with our finding of no association 
between preterm delivery and postpartum lipid levels after accounting 
for hypertensive disorders,5-7 but two US studies found lower HDL-C 
levels6 and higher rates of hypercholesterolemia among women with a 
history of preterm delivery.21 Except for one study21 indicating an in-
creased risk of type 2 diabetes after preterm birth, no previous studies 
have shown evidence for associations between preterm delivery and 
postpartum glucose6,7 or CRP5-7,22 levels when restricting to sponta-
neous deliveries or accounting for hypertensive disorders.
Although the etiology of preterm delivery is not well under-
stood, there are probably many causes.9 The distribution of these 
causes may differ by study population, which could explain why 
some previous studies observed associations between preterm 
delivery and CVD risk factors postpartum. Our study population 
is fairly representative of Norway23 with a relatively low preterm 
delivery rate of 7% (before study-specific exclusions). Studies that 
found associations between preterm delivery and CVD risk factors, 
such as the US-based CARDIA and Nurses’ Health studies, tended 
to have higher rates of preterm delivery. The CARDIA study had 
a preterm delivery rate at 25%.5 In the Nurses’ Health Study II, 
the increased risk of hypertension and hypercholesterolemia as-
sociated with preterm delivery appeared to be driven by the very 
preterm group, which in their study population accounted for 2% 
compared with 1% in our population.21 The causes of preterm de-
livery in these populations may be more strongly associated with 
metabolic syndrome, leading to the associations they observed.
Our study extends the work of Magnussen et al4 who exam-
ined cardiovascular risk factors before delivery using only the 
second HUNT survey. We similarly found that pre-pregnancy 
non-fasting glucose was associated with shorter gestation length 
and found some evidence for a less favorable pre-pregnancy lipid 
profile before preterm delivery. Two previous studies also found 
higher glucose before preterm delivery24,25 and there is some 
F I G U R E  4   Mean clinically measured cardiovascular disease (CVD) risk factors at age 40 years by gestation length of first delivery. 
Estimates are adjusted for age, HUNT survey, age at first delivery, highest obtained education level, family history of CVD, smoking at age 
20 years, and time since last meal. Covariates are fixed at their means
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evidence that glucose intolerance is involved in the pathogenesis 
of spontaneous preterm delivery.26 However, it is unclear why dif-
ferences in glucose levels based on gestation length do not persist 
postpartum.
A strength of our study was the use of life course trajectories 
to provide a more holistic examination of differences in risk factors 
based on preterm delivery history. With measurements both be-
fore and after pregnancy and a wide range of ages, we were able to 
examine differences in risk factors over a longer period of follow 
up than previous studies. We were also able to adjust for known 
predictors of CVD risk including education, smoking, and family 
history of CVD to ensure that the associations we observed were 
not just due to these well-established factors, and to adjust for 
age and HUNT survey occasion to reduce the influence of secular 
trends on trajectories.27 We controlled for time since last meal to 
reduce the potential for error introduced by measuring non-fasting 
risk factors.
The registry-based definition of gestation length was a 
strength of our study; however, ultrasound dating was unavail-
able for the majority of deliveries included in this study. We 
would expect error introduced by using last menstrual period 
to bias estimates towards the null, which could explain, in part, 
our null findings, especially for older women who did not have 
ultrasound dating as an option for their first pregnancy. As last 
menstrual period tends to classify more deliveries as preterm,28 
we conducted sensitivity analyses excluding deliveries that were 
unusually large for their gestational age and found no differences 
in results. Another potential source of misclassification in this 
study was antihypertensive medication use, which we accounted 
for using the recommended12,13 approach of adding constants to 
F I G U R E  5   Mean serum levels of cardiovascular disease (CVD) risk factors at age 40 years by gestation length of first delivery. Estimates 
are adjusted for age, HUNT survey, age at first delivery, highest obtained education level, family history of CVD, smoking at age 20 years, 
and time since last meal. Covariates are fixed at their means
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observed blood pressure measurements for users. Results were 
not sensitive to the choice of constants added. In addition, an-
tihypertensive use did not differ based on preterm delivery his-
tory (8.8% among women with a preterm first delivery vs 8.9% 
otherwise), making it unlikely that trajectories were differentially 
affected. We did not have data on statin use, which increased in 
Norway starting in the late 1990s29 and may have effected lipid 
measurements taken during HUNT3 (2006-08). If statin use was 
differential by preterm delivery history then this could have made 
lipid trajectories appear more similar at later ages when statin use 
was higher; however, there is no evidence from previous ages that 
women with a preterm delivery would have been more likely to be 
prescribed statins given their risk factor levels.
American Heart Association guidelines30 recommend that 
women with a history of pregnancy complications, including 
preterm delivery, should have their risk factors carefully moni-
tored and controlled. Our study sought to expand these guidelines 
by identifying which risk factors to target in this group of women 
and when this should occur across the life course. However, we 
did not find evidence that this group of women should be specif-
ically targeted for cardiovascular risk factor control or that inter-
ventions should be directed toward any particular risk factor. Our 
study suggests that women who had a preterm delivery may be 
too heterogeneous a group to recommend a uniform approach to 
CVD prevention.
5  | CONCLUSION
Overall, we found that women who experienced a preterm first de-
livery were on a similar cardiovascular trajectory as those with a first 
term delivery, based on commonly measured cardiovascular risk fac-
tors in early to mid-life. Our findings were unexpected given the con-
sistent evidence that women with a preterm delivery history have a 
greater risk of CVD,1 with a two-fold greater risk of CVD death seen 
even among spontaneous preterm deliveries in Norway.31 Although 
preterm birth is associated with slight increases in cardiovascular risk 
factors within some populations, the lack of observed differences in 
risk factor trajectories in our population supports the hypothesis that 
the association between preterm delivery and CVD is not explained 
to a large extent by an increase in CVD risk factors postpartum.32 In 
ours and comparable populations, other factors that could explain 
the association between preterm delivery and CVD are unknown but 
may include common genetic factors, low grade inflammation not 
captured in our measurement of hs-CRP, or the stress of a preterm 
delivery directly leading to increased CVD events.
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